Levo-α-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial

BACKGROUND: Due to potential proarrhythmic side-effects levo-α-Acetylmethadol (LAAM) is currently not available in EU countries as maintenance drug in the treatment of opiate addiction. However, recent studies and meta-analyses underline the clinical advantages of LAAM with respect to the reduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieneke, H, Conrads, H, Wolstein, J, Breuckmann, F, Gastpar, M, Erbel, R, Scherbaum, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352205/
https://www.ncbi.nlm.nih.gov/pubmed/19258204
http://dx.doi.org/10.1186/2047-783X-14-1-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352205/
https://www.ncbi.nlm.nih.gov/pubmed/19258204
http://dx.doi.org/10.1186/2047-783X-14-1-7

Ejemplares similares